SC

Satyarth Chaudhary

Active Director Director DIN 08146598
DIN 08146598 First appointment May 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2018
Shareholding value •••• Premium profile

About Satyarth Chaudhary

Data last updated:

Satyarth Chaudhary is a Director at Rcsat Pharmaceuticals Private Limited (since 2018). The company operates in Pharma. Rcsat Pharmaceuticals Private Limited reported revenue of ₹66.7 Lakh (FY 2025).

DIN 08146598
Primary Designation Director
Industry Pharma
First Appointment 31 May 2018
Oldest Company Age 9 yrs
Largest company Rcsat Pharmaceuticals Private Limited · ₹66.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 May 20182016₹66.7 Lakh (FY 2025)Active

Board colleagues of Satyarth Chaudhary

Directorship timeline

Open interactive timeline →
Rcsat Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Satyarth Chaudhary

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Satyarth Chaudhary

Satyarth Chaudhary currently holds 1 directorship: Rcsat Pharmaceuticals Private Limited (Director, since 31 May 2018, revenue ₹66.7 Lakh (FY 2025)).

Satyarth Chaudhary was first appointed on 31 May 2018 as Director at Rcsat Pharmaceuticals Private Limited.

The current boards of Satyarth Chaudhary's companies include Aparna Rajnath Singh (Rcsat Pharmaceuticals Private Limited), Chandresh (Rcsat Pharmaceuticals Private Limited), Ram Chander (Rcsat Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available